- Home
- API vs MNMD Comparison
API vs MNMD Comparison
Compare API & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- API
- MNMD
- Stock Information
- Founded
- API 2013
- MNMD 2019
- Country
- API United States
- MNMD United States
- Employees
- API N/A
- MNMD N/A
- Industry
- API Computer Software: Prepackaged Software
- MNMD Pharmaceuticals and Biotechnology
- Sector
- API Technology
- MNMD Health Care
- Exchange
- API Nasdaq
- MNMD Nasdaq
- Market Cap
- API 419.4M
- MNMD 485.5M
- IPO Year
- API 2020
- MNMD N/A
- Fundamental
- Price
- API $4.65
- MNMD $7.97
- Analyst Decision
- API
- MNMD Strong Buy
- Analyst Count
- API 0
- MNMD 9
- Target Price
- API N/A
- MNMD $28.75
- AVG Volume (30 Days)
- API 2.3M
- MNMD 1.1M
- Earning Date
- API 11-25-2024
- MNMD 11-07-2024
- Dividend Yield
- API N/A
- MNMD N/A
- EPS Growth
- API N/A
- MNMD N/A
- EPS
- API N/A
- MNMD N/A
- Revenue
- API $134,844,000.00
- MNMD N/A
- Revenue This Year
- API N/A
- MNMD N/A
- Revenue Next Year
- API $8.09
- MNMD N/A
- P/E Ratio
- API N/A
- MNMD N/A
- Revenue Growth
- API N/A
- MNMD N/A
- 52 Week Low
- API $1.65
- MNMD $3.35
- 52 Week High
- API $6.64
- MNMD $12.22
- Technical
- Relative Strength Index (RSI)
- API 48.85
- MNMD 56.42
- Support Level
- API $4.21
- MNMD $6.89
- Resistance Level
- API $6.64
- MNMD $7.58
- Average True Range (ATR)
- API 0.67
- MNMD 0.46
- MACD
- API -0.18
- MNMD -0.03
- Stochastic Oscillator
- API 19.34
- MNMD 55.25
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.